U.S. Logistics Stock News

Surging bond yields, stubborn inflation pressures and a cooler housing market are putting mortgage related stocks under the spotlight right now. For investors, that mix can create sharp winners and quiet laggards as funding costs, asset values and dividends are all tested at once. This article walks through three stocks exposed to these cross currents, explaining how each is positioned so you can decide where they may fit, or may not fit, in your portfolio. The three stocks below are a sample...

NVR stock has delivered a 25.7% total return over the past five years, yet recent share price weakness and a low overall value score raise questions about how much upside is left at around US$6,375 per share. The intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to NVR being roughly fairly valued, while traditional earnings multiples still screen the stock as undervalued. Over five years, NVR has returned 25.7%, which is a solid but not spectacular outcome for...

UGI (UGI) is back in focus after reporting third quarter 2026 results that combined a net loss from continuing operations with reaffirmed full year guidance and a fresh quarterly dividend declaration. See our latest analysis for UGI. UGI’s share price is US$35.26 after a 1-day share price return of 0.46% and a 7-day return of 2.86%. Even so, the stock is down 6.30% year to date, while the 3-year total shareholder return of 77.64% contrasts with a 5-year total shareholder return that is...

Allient (ALNT) is back in focus after reporting record margins, a 1.31x book-to-bill ratio, and strong order intake across industrial and aerospace segments, alongside momentum recognition and positive earnings estimate revisions. See our latest analysis for Allient. The latest earnings and dividend announcement comes after a sharp re-rating in Allient’s share price, with a 30-day share price return of 23.54% and a 90-day share price return of 78.84%. Over longer horizons, momentum has been...

ANI Pharmaceuticals stock reacts to earnings and guidance update ANI Pharmaceuticals (ANIP) is in focus after releasing second quarter and first half 2026 results, alongside a reaffirmed full year net revenue outlook between $1,080 million and $1,140 million. See our latest analysis for ANI Pharmaceuticals. Despite the stronger recent earnings, ANI Pharmaceuticals’ share price has been under pressure, with a 7 day share price return of down 9.5% and a 1 year total shareholder return of down...

In early August 2026, GXO Logistics reported Q2 sales of US$3,441 million, slightly higher net income of US$25 million, and modestly lower earnings per share, while first-half results showed a shift from a net loss to a profit. The quarter also delivered record new business wins of US$410 million and over US$1 billion in incremental 2026 revenue already secured, highlighting how contract momentum is reshaping the company’s earnings profile. Next, we’ll examine how this record US$410...

Easterly Government Properties (DEA) recently raised its full year 2026 earnings guidance, shortly after reporting second quarter results that showed higher revenue but lower net income and earnings per share compared with a year earlier. See our latest analysis for Easterly Government Properties. At a share price of $24.86, Easterly Government Properties has a year to date share price return of 16.66%, while the 1 year total shareholder return of 21.24% contrasts with a decline over the 3...

Melco Resorts & Entertainment (MLCO) is back in focus after Q2 2026 results showed pressure on Macau operations from weaker visitation and VIP win rates, along with fresh details on future capital returns. See our latest analysis for Melco Resorts & Entertainment. Following Melco Resorts & Entertainment’s Q2 update, the stock is trading at US$5.50, with a 1 month share price return of 5.97% but a year to date share price decline of 26.76% and a 1 year total shareholder return decline of...

NNN REIT (NNN) drew fresh attention after filing and completing follow on equity offerings alongside its second quarter 2026 results, updated AFFO guidance, and a 3.3% dividend increase. See our latest analysis for NNN REIT. Over the past year, NNN REIT’s share price has risen, with a year to date share price return of 16.97% and a 1 year total shareholder return of 18.88%. This suggests recent equity issuance and guidance updates are being weighed against a longer track record of 3 year and...

Global Payments (GPN) has drawn investor attention after reporting second quarter 2026 results that combined higher sales with sharply lower net income and a net loss for the first half of the year. See our latest analysis for Global Payments. Global Payments' share price has reacted strongly to the latest earnings and dividend announcement, with a 1 month share price return of 24.96% and a 3 month share price return of 40.32%. However, the 5 year total shareholder return of a 38.92% decline...

Heightened concern about AI driven cyberattacks and upcoming congressional scrutiny of AI executives has pushed Palo Alto Networks (PANW) into the spotlight, as investors reassess which cybersecurity stocks are set up for AI era demand. See our latest analysis for Palo Alto Networks. Palo Alto Networks has ridden this wave of AI focused attention with strong momentum, with a 30 day share price return of 12.22% and a 90 day share price return of 63.08%. The 5 year total shareholder return of...

In early August 2026, NRG Energy, Inc. reported second-quarter results showing sales rising to US$7,481 million and net income reaching US$506 million, reversing a net loss a year earlier and lifting earnings per share from continuing operations to US$2.31 on a diluted basis. Over the first half of 2026, however, net income of US$631 million was slightly lower than the prior year even as sales grew to US$17.74 billion, highlighting that the strong quarterly rebound comes alongside more...

Pentair plc is facing a securities fraud class action in the U.S. District Court for the Southern District of New York, after investors alleged the company misled the market about Pool segment inventory issues that later coincided with weaker segment sales and income. The lawsuit centers on claims that Pentair downplayed the impact of destocking in its Pool channel, even as that segment contributed about 37% of net sales and 46% of reportable income in fiscal 2025. We’ll now examine how the...

InvenTrust Properties (IVT) drew fresh investor attention after its second quarter 2026 update, which paired a renewed push on acquisitions with higher full year earnings guidance and commentary on its capital flexibility. See our latest analysis for InvenTrust Properties. After the Q2 2026 earnings call and guidance revision, InvenTrust Properties has seen choppy trading, with a 30 day share price return down 5.6%. Yet the year to date share price return of 20.37% and the 3 year total...

Grupo Aeroméxico. de stock has fallen 27.8% year to date, yet the company still screens as undervalued on a broad set of valuation checks. That gap between weak recent returns and a strong value score is what investors are weighing now. Year to date, the share price is down 27.8%, which raises the question of whether sentiment has moved further than the underlying value. Future profitability and cash generation from Grupo Aeroméxico. de's core airline operations can support the current...

Earlier this week, VIAVI Solutions Inc. launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and carrier support up to 23.6 GHz, billed as the industry's first emulator tailored for next-generation 6G and Wi-Fi 7/8 testing and compatible with complex cellular, Wi-Fi, military and aerospace RF technologies. The upgrade, which builds on Viavi’s acquisition of Spirent’s channel emulation assets and integrates with TM500, TeraVM and FR3 MIMO converters...

Annexon’s recent updates highlighted wider Q2 2026 net loss of US$55.35 million alongside significant pipeline progress in geographic atrophy and Guillain-Barré syndrome, backed by access to up to US$200 million in non-dilutive financing that extends its cash runway into 2028. A key development was the adoption of a dual primary endpoint in the pivotal ARCHER II trial for vonaprument, potentially broadening how regulators and clinicians assess vision-preserving benefit in geographic atrophy...

Why Symbotic Stock Is Back in Focus After Q3 Results Symbotic (SYM) is back on investor radar after third quarter earnings, fresh fourth quarter 2026 revenue guidance, and a series of product rollouts and acquisitions tied to key customer Walmart. See our latest analysis for Symbotic. Over the past year Symbotic has seen the share price fall 35.6% year to date, even though the 5 year total shareholder return of about 4x suggests earlier investors have still done well. Recent Q3 earnings,...

Zenas BioPharma, Inc. reported second-quarter 2026 revenue of US$1,000,000 and a net loss of US$111,460,000, with losses widening sharply versus a year earlier and first-half revenue dropping to US$1,000,000 from US$10,000,000. Alongside these results, the company announced past and upcoming leadership changes, including its Chief Financial Officer shifting to a Strategic Advisor role and the appointment of industry veteran Christy Oliger to the board, highlighting meaningful shifts in...

Eversource Energy stock has delivered a 28.7% return over the past three years, while the latest valuation checks send mixed signals, with the Dividend Discount Model suggesting the shares trade at a premium to intrinsic value and the market multiples pointing closer to a discount. For investors, that split raises the question of whether the current US$72.22 share price already reflects much of the good news or still leaves room based on traditional ratios. Eversource Energy’s 28.7% three...

SELLAS Life Sciences Group, Inc. reported past second-quarter 2026 results, with net loss rising to US$9.61 million from US$6.60 million a year earlier, while basic loss per share from continuing operations narrowed to US$0.05 from US$0.07. Despite higher cumulative net losses in the first half of 2026, the company’s investment case is increasingly shaped by late-stage oncology programs such as galinpepimut-S and SLS009, supported by collaborations with Merck, GenFleet Therapeutics, and...

Westlake stock has delivered a decline of about 35.0% over the past three years, yet current valuation checks and market multiples suggest the shares now sit closer to a fair range rather than an obvious bargain or an obvious premium. The roughly 35.0% share price decline over three years points to a company where past returns have been weak, even though the current valuation no longer looks stretched in either direction. For Westlake, the long term outlook for cash generation can support...

Q2 earnings and guidance shift focus to EVERTEC fundamentals EVERTEC (EVTC) has drawn investor attention after its second quarter 2026 earnings, which combined higher sales with sharply lower net income and an updated outlook for the rest of the year. The company reported Q2 sales of US$274.82 million compared with US$229.61 million a year earlier, while net income was US$5.41 million versus US$40.47 million. Basic earnings per share from continuing operations were US$0.09 compared with...

Sprinklr (NYSE:CXM) appointed Microsoft Search & AI President Dr. Jordi Ribas to its Board of Directors. Ribas brings experience leading generative AI efforts and major product teams within Microsoft. The board change highlights Sprinklr's focus on AI driven customer experience products for enterprise clients. Consider reviewing other companies in similar segments that may show a strong founder influence alongside AI focused product roadmaps through 20 top founder-led companies. NYSE:CXM...